Cited 0 times in

SGLT2 inhibitor protects cardiomyocytes against palmitate-induced lipotoxicity by increasing activation of AMPK and lipid oxidations

Lee, Han Byeol | Choi, Sung-E | Kang, Yup | Kim, Tae Ho | Seo, Mi Hye | Lee, Min Jeong | Lee, Nami | Moon, Hyun Uk | Han, Seung Jin | Kim, Dae Jung | Lee, Kwan-Woo
Department of Endocrinology & Metabolism, Ajou University School of Medicine  | Department of Physiology, Ajou University School of Medicine
Low doses of palmitates evoked lipotoxicity in cardiomyocytes. Although SGLT2 expression was less in myocardial cells, treatment of SGLT2 inhibitor dramatically reduced palmitate-induced expression levels of inflammatory cytokines, such as IL-1beta and TNF-alpha. Immunoblotting analysis showed treatment of cardiomyocytes, with SGLT2 inhibitor, recovered impaired insulin signaling, such as phospho-AKT, but total AKT did not change. SGLT2 inhibitor also restored insulin-stimulated glucose uptake, which was destroyed by lipotoxicity. Treatment with SGLT2 inhibitor decreased the level of ER stress markers as well as inflammatory signaling markers. In particular, SGLT2 inhibitor stimulated phosphorylation of AMPK and fatty acid beta-oxidation. Cardiomyocyte exposure to high doses of palmitates evoked apoptotic features such as caspase 3 activation and DNA fragmentations. But pretreatment of SGLT2 inhibitor significantly protected palmitate-induced apoptotic features.
Appears in Collections:
Poster > School of Medicine / Graduate School of Medicine > Department of Endocrinology & Metabolism
Poster > School of Medicine / Graduate School of Medicine > Department of Physiology
Ajou Authors
대학, 내분비대사내과학교실  |  대학, 생리학교실
Files in This Item:


해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.